ESC 365 - Lower dose direct oral anticoagulation or warfarin in atrial fibrillation. Which one is the best when time on therapeutic range information is available?

EHRA Premium Access

Lower dose direct oral anticoagulation or warfarin in atrial fibrillation. Which one is the best when time on therapeutic range information is available?

Session: Atrial Fibrillation - Round 7 - Stroke - Prevention

Topic: Stroke in Atrial Fibrillation

Speaker: Mr A. Luojus (Helsinki, FI)

Event: EHRA 2023

Congress Presentation

Add to my library

About the speaker

Mr Alex Luojus

University of Helsinki, Helsinki (Finland)

0 follower

7 more presentations in this session

Reduction of major gastrointestinal bleeding risk with proton pump inhibitor therapy in patients with atrial fibrillation receiving direct oral anticoagulant

Speaker: Doctor S. Lee (Seoul, KR)

Systolic, diastolic blood pressure and pulse pressure and risk of stroke in young aged patients with atrial fibrillation

Speaker: Doctor S. Lee (Seoul, KR)

Brain lesions and cognitive decline in patients with atrial fibrillation

Speaker: Doctor E. Hennings (Basel, CH)

Telemedicine: the future of personalised atrial fibrillation care in a post pandemic world?

Speaker: Doctor I. Koev (Leicester, GB)

Predictive value of left and right atrial strain for the detection of atrial fibrillation in patients with cryptogenic stroke and implant of loop recorder

Speaker: Doctor G. Arabia (Brescia, IT)

Access the full session

Atrial Fibrillation - Round 7 - Stroke - Prevention

Speakers: Mr A. Luojus, Doctor S. Lee, Doctor S. Lee, Doctor E. Hennings, Doctor I. Koev...

About the event

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources